155 related articles for article (PubMed ID: 8445430)
21. PCR assessment of bone marrow status in 'isolated' extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia.
Goulden N; Langlands K; Steward C; Katz F; Potter M; Chessells J; Oakhill A
Br J Haematol; 1994 Jun; 87(2):282-5. PubMed ID: 7947268
[TBL] [Abstract][Full Text] [Related]
22. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia.
Roberts WM; Estrov Z; Ouspenskaia MV; Johnston DA; McClain KL; Zipf TF
N Engl J Med; 1997 Jan; 336(5):317-23. PubMed ID: 9011783
[TBL] [Abstract][Full Text] [Related]
23. Characterization of clonal immunoglobulin heavy chain and I cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia.
Marshall GM; Kwan E; Haber M; Brisco MJ; Sykes PJ; Morley AA; Toogood I; Waters K; Tauro G; Ekert H
Leukemia; 1995 Nov; 9(11):1847-50. PubMed ID: 7475273
[TBL] [Abstract][Full Text] [Related]
24. Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia.
Mortuza FY; Papaioannou M; Moreira IM; Coyle LA; Gameiro P; Gandini D; Prentice HG; Goldstone A; Hoffbrand AV; Foroni L
J Clin Oncol; 2002 Feb; 20(4):1094-104. PubMed ID: 11844835
[TBL] [Abstract][Full Text] [Related]
25. Residual disease detection using fluorescent polymerase chain reaction at 20 weeks of therapy predicts clinical outcome in childhood acute lymphoblastic leukemia.
Evans PA; Short MA; Owen RG; Jack AS; Forsyth PD; Shiach CR; Kinsey S; Morgan GJ
J Clin Oncol; 1998 Nov; 16(11):3616-27. PubMed ID: 9817283
[TBL] [Abstract][Full Text] [Related]
26. Study of minimal residual disease in B-cell lineage acute lymphoblastic leukemia of childhood, using clone-specific probes.
Botsonis T; Tsangaris GT; Mikraki V; Tzortzatou-Stathopoulou F
Anticancer Res; 1999; 19(3B):2211-20. PubMed ID: 10472333
[TBL] [Abstract][Full Text] [Related]
27. Detection of clonality in childhood B-lineage acute lymphoblastic leukaemia by the polymerase chain reaction.
Potter MN; Steward CG; Maitland NJ; Oakhill A
Leukemia; 1992 Apr; 6(4):289-94. PubMed ID: 1588791
[TBL] [Abstract][Full Text] [Related]
28. Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group.
Eckert C; Henze G; Seeger K; Hagedorn N; Mann G; Panzer-Grümayer R; Peters C; Klingebiel T; Borkhardt A; Schrappe M; Schrauder A; Escherich G; Sramkova L; Niggli F; Hitzler J; von Stackelberg A
J Clin Oncol; 2013 Jul; 31(21):2736-42. PubMed ID: 23775972
[TBL] [Abstract][Full Text] [Related]
29. Early resistance to therapy during induction in childhood acute lymphoblastic leukemia.
Brisco MJ; Sykes PJ; Dolman G; Hughes E; Neoh SH; Peng L; Snell LE; Toogood IR; Rice MS; Morley AA
Cancer Res; 2000 Sep; 60(18):5092-6. PubMed ID: 11016634
[TBL] [Abstract][Full Text] [Related]
30. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study.
Bowman WP; Shuster JJ; Cook B; Griffin T; Behm F; Pullen J; Link M; Head D; Carroll A; Berard C; Murphy S
J Clin Oncol; 1996 Apr; 14(4):1252-61. PubMed ID: 8648381
[TBL] [Abstract][Full Text] [Related]
31. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.
Preudhomme C; Dervite I; Wattel E; Vanrumbeke M; Flactif M; Lai JL; Hecquet B; Coppin MC; Nelken B; Gosselin B
J Clin Oncol; 1995 Apr; 13(4):812-20. PubMed ID: 7707106
[TBL] [Abstract][Full Text] [Related]
33. Monitoring of adult B-cell lineage acute lymphoblastic leukemia: validation of a simple method for detecting immunoglobulin heavy chain gene clonality.
Salo A; Pakkala S; Jansson SE; Helminen P; Palotie A
Leukemia; 1993 Sep; 7(9):1459-65. PubMed ID: 8371595
[TBL] [Abstract][Full Text] [Related]
34. Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia.
Uckun FM; Kersey JH; Haake R; Weisdorf D; Nesbit ME; Ramsay NK
N Engl J Med; 1993 Oct; 329(18):1296-301. PubMed ID: 8413410
[TBL] [Abstract][Full Text] [Related]
35. Detection of minimal residual disease in leukemia using polymerase chain reaction and restriction analysis.
Wu N; Lu S; Zhu P; Liu L; Peng Y
Chin Med J (Engl); 1997 Jan; 110(1):73-7. PubMed ID: 9594329
[TBL] [Abstract][Full Text] [Related]
36. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
37. Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved.
Ouspenskaia MV; Johnston DA; Roberts WM; Estrov Z; Zipf TF
Leukemia; 1995 Feb; 9(2):321-8. PubMed ID: 7869771
[TBL] [Abstract][Full Text] [Related]
38. Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation. Nagoya BMT Group.
Mizuta S; Ito Y; Kohno A; Kiyoi H; Miyamura K; Tanimoto M; Takamatsu J; Naoe T; Morishima Y; Ueda R; Saito H
Bone Marrow Transplant; 1999 Oct; 24(7):777-84. PubMed ID: 10516682
[TBL] [Abstract][Full Text] [Related]
39. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
Bührer C; Hartmann R; Fengler R; Rath B; Schrappe M; Janka-Schaub G; Henze G
J Clin Oncol; 1996 Oct; 14(10):2812-7. PubMed ID: 8874343
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
Gaynon PS; Harris RE; Altman AJ; Bostrom BC; Breneman JC; Hawks R; Steele D; Zipf T; Stram DO; Villaluna D; Trigg ME
J Clin Oncol; 2006 Jul; 24(19):3150-6. PubMed ID: 16717292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
